{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:12:48Z","timestamp":1790727168892,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"am","delay-in-days":310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jiac.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T19:03:23Z","timestamp":1657998203000},"page":"1445-1451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in Japan"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9722-7663","authenticated-orcid":false,"given":"Tetsuya","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ohge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Weerdenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Spiessens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"van Geet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs","family":"van den Hoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2097-3761","authenticated-orcid":false,"given":"Yoshikazu","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9583-8126","authenticated-orcid":false,"given":"Jan","family":"Poolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Geurtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.07.001_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/jiv429","article-title":"Extraintestinal pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field","volume":"213","author":"Poolman","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.001_bib2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(17)30108-1","article-title":"Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial","volume":"17","author":"Huttner","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.001_bib3","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.35.30329","article-title":"Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014","volume":"21","author":"Bou-Antoun","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jiac.2022.07.001_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/CMR.00002-14","article-title":"Population-based epidemiology and microbiology of community-onset bloodstream infections","volume":"27","author":"Laupland","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2022.07.001_bib5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1469-0691.2008.02089.x","article-title":"Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region","volume":"14","author":"Laupland","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2022.07.001_bib6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/1469-0691.12028","article-title":"The changing epidemiology of bacteraemias in Europe: trends from the European antimicrobial resistance surveillance system","volume":"19","author":"de Kraker","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2022.07.001_bib7","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10609.1","article-title":"Escherichia coli ST131: a multidrug-resistant clone primed for global domination","volume":"6","author":"Pitout","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.jiac.2022.07.001_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01596-17","article-title":"Comparative genomic analysis of globally dominant ST131 clone with other epidemiologically successful extraintestinal pathogenic Escherichia coli (ExPEC) lineages","volume":"8","author":"Shaik","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.jiac.2022.07.001_bib9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/cid\/ciaa210","article-title":"Epidemiology of Escherichia coli bacteremia: a systematic literature review","volume":"72","author":"Bonten","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.001_bib10","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1017\/S0950268814000211","article-title":"Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome","volume":"142","author":"Roubaud Baudron","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jiac.2022.07.001_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1286-4579(03)00049-2","article-title":"Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem","volume":"5","author":"Russo","year":"2003","journal-title":"Microb Infect"},{"key":"10.1016\/j.jiac.2022.07.001_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fmicb.2012.00009","article-title":"Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance","volume":"3","author":"Pitout","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2022.07.001_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13054-018-2186-7","article-title":"Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study","volume":"22","author":"Abe","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2022.07.001_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.35772\/ghm.2020.01005","article-title":"Road to comprehensive estimation of antimicrobial resistance (AMR) disease burden in Japan","volume":"2","author":"Tsuzuki","year":"2020","journal-title":"Glob Health Med"},{"key":"10.1016\/j.jiac.2022.07.001_bib17","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1038\/s41598-020-59830-6","article-title":"Characteristics and outcomes of bacteremia among ICU-admitted patients with severe sepsis","volume":"10","author":"Komori","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2022.07.001_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043774","article-title":"National database study of trends in bacteraemia aetiology among children and adults in Japan: a longitudinal observational study","volume":"11","author":"Kusama","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiac.2022.07.001_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jiac.2019.10.017","article-title":"National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan","volume":"26","author":"Tsuzuki","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.07.001_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijid.2021.05.018","article-title":"Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: a population-level study, Japan, 2015\u2fff2018","volume":"108","author":"Tsuzuki","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.001_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1186\/s12913-018-3604-x","article-title":"Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories","volume":"18","author":"Tsutsui","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jiac.2022.07.001_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jiac.2019.11.003","article-title":"Multicenter surveillance of the epidemiology of gram-negative bacteremia in Japan","volume":"26","author":"Kosai","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.07.001_bib23","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/jac\/dkv017","article-title":"CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic","volume":"70","author":"Matsumura","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2022.07.001_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1473-3099(18)30803-X","article-title":"Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial","volume":"19","author":"Frenck","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.001_bib25","article-title":"Global distribution of extraintestinal pathogenic Escherichia coli (ExPEC) O serotypes and antibiotic resistance in blood isolates collected from patients in a 7-year surveillance study","volume":"10","author":"Weerdenburg","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.001_bib26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1128\/br.41.3.667-710.1977","article-title":"Serology, chemistry, and genetics of O and K antigens of Escherichia coli","volume":"41","author":"Orskov","year":"1977","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.jiac.2022.07.001_bib28","article-title":"Comparison of O-antigen gene clusters of all O-serogroups of Escherichia coli and proposal for Adopting a new nomenclature for O-typing","volume":"11","author":"DebRoy","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2022.07.001_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab006","article-title":"Ten years of population-level genomic Escherichia coli and Klebsiella pneumoniae serotype surveillance informs vaccine development for invasive infections","author":"Lipworth","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.001_bib31","article-title":"O-antigen targeted vaccines against E. coli may be useful in reducing morbidity, mortality and antimicrobial resistance","author":"Royer","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.001_bib32","first-page":"1040","article-title":"Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance","volume":"72","author":"Matsumura","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2022.07.001_bib33","first-page":"181","article-title":"Current trends in antimicrobial resistance of Escherichia coli","volume":"416","author":"Paitan","year":"2018","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jiac.2022.07.001_bib34","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.carres.2010.04.023","article-title":"Structures of the O-antigens of Escherichia coli O13, O129, and O135 related to the O-antigens of Shigella flexneri","volume":"345","author":"Perepelov","year":"2010","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.jiac.2022.07.001_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jac\/dkn463","article-title":"Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread","volume":"63","author":"Suzuki","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2022.07.001_bib36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijantimicag.2009.12.012","article-title":"Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors","volume":"35","author":"Uchida","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2022.07.001_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2022.07.001_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000336129","article-title":"Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan","volume":"58","author":"Yokota","year":"2012","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2022.07.001_bib39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jiac.2017.02.002","article-title":"JAID\/JSC guidelines for clinical management of infectious disease 2015 - urinary tract infection\/male genital infection","volume":"23","author":"Yamamoto","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.07.001_bib40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jiac.2020.01.004","article-title":"The third national Japanese antimicrobial susceptibility pattern surveillance program: bacterial isolates from complicated urinary tract infection patients","volume":"26","author":"Kobayashi","year":"2020","journal-title":"J Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:04:55Z","timestamp":1761159895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22001970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1341321X22001970"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.07.001","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}